# A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

> **NCT01801397** · PHASE3 · UNKNOWN · sponsor: **University of Zurich** · enrollment: 10 (estimated)

## Conditions studied

- Low Bone Mass in Anorexia Nervosa Patients

## Interventions

- **DRUG:** osteoanabolic therapy

## Key facts

- **NCT ID:** NCT01801397
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801397, "A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01801397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*